Who invested in Avalia Immunotherapies?
Avalia Immunotherapies's investors include Callaghan Innovation and Powerhouse Ventures.
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$6Kraised across 1 round since 2020, from 1 source
Avalia Immunotherapies's investors include Callaghan Innovation and Powerhouse Ventures.
Avalia Immunotherapies has raised $6K across 1 round since 2020.
Avalia Immunotherapies's most recent round was a Grant of $6K in Oct 2020.
Its most recent round, $6K in Oct 2020, is also its largest on record.
Avalia Immunotherapies's first round on record, in Oct 2020, was backed by Callaghan Innovation and Powerhouse Ventures.
Avalia Immunotherapies's latest named round is a Grant, in Oct 2020.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.